Campbell & CO Investment Adviser LLC Aldeyra Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
SELL
$6.11 - $8.16 $4,386 - $5,858
-718 Reduced 6.36%
10,569 $70,000
Q2 2023

Aug 11, 2023
SELL
$7.11 - $11.89 $574,637 - $960,961
-80,821 Reduced 87.75%
11,287 $94,000
Q1 2023

May 11, 2023
BUY
$5.77 - $9.93 $531,463 - $914,632
92,108 New
92,108 $914,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $283M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email